HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 20, No 12, December 2016 – Medical Imaging Technology       » Climate Change Could Hurt Coffee, Help Banana Production       » Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific       » Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease       » NUS Scientists Discover the "Switch" that Makes Breast Cancer Cells Aggressive      
INSIDE INDUSTRY
Agilent Technologies’ and PREMIER Biosoft's platforms work together to advance lipidomics research
Agilent Technologies Inc. and PREMIER Biosoft announced that they will each support the combined use of their respective technologies to help clinical researchers advance lipidomics research. By integrating complementary technologies, researchers can seamlessly generate and process data, then map complex lipidomic networks to learn more about lipid metabolism associated with disease.

The power of Agilent's industry-leading time-of-flight and quadrupole time-of-flight mass spectrometers and Pathway Architect software combined with Premier Biosoft's SimLipid 3.3 identification and quantification software enables researchers to overcome many of the obstacles inherent in lipid identification and analysis. This will give them a distinct advantage in their efforts to map the lipid pathways associated with metabolic disease.

“Just as challenging as mapping and sequencing the human genome is identifying and sequencing the thousands of lipid species involved in human metabolism,” said Dr. Daniel B. Kassel, Agilent's senior director of LC/MS global marketing. “By utilizing this combined network of technologies, researchers can be confident in the analytical strength they have come to expect from Agilent and from the advanced lipid identification capabilities provided in PREMIER Biosoft's SimLipid software.”

“By connecting these complementary technologies, researchers can maximize the analytical capabilities of Agilent's high-end MS instrumentation and software with our high-throughput MS and MS/MS data analysis tools,” said Arun Apte, Chief Executive Officer at PREMIER Biosoft. “Our SimLipid software supports data from Agilent's well-known MassHunter, Mass Profiler Professional and Pathway Architect software programs, creating an integrated workflow for the accurate and efficient identification and contextualization of lipids on metabolic pathways.”

Click here for the complete issue.

NEWS CRUNCH  
news Accuron Technologies' MedTech Division Invests into AWAK Technologies
news Philips introduces PerformanceBridge suite of operational performance improvement software and services for radiology departments
news Give a Gift that Will Last a Lifetime this Holiday Season with Smile Train
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Lungs & Respiratory System
February:
Cancer Research, Treatment/Technology
March:
Traditional Chinese Medicines
April:
Diabetics Technology
May:
The Piece of Your Mind - Brain Health/Science
June:
Featuring Biotech Start-Ups/Companies
July:
Food Science & Technology
August:
Eye Care/ Eye Health
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy